May 2, 2018 / 8:49 PM / 21 days ago

BRIEF-H Lundbeck says FDA updates Trintellix label to include data showing improvement in processing speed

May 2 (Reuters) - H Lundbeck A/S:

* REG-FDA UPDATES TRINTELLIX® (VORTIOXETINE) LABEL TO INCLUDE DATA SHOWING IMPROVEMENT IN PROCESSING SPEED, AN IMPORTANT ASPECT OF COGNITIVE FUNCTION IN ACUTE MAJOR DEPRESSIVE DISORDER (MDD)

* U.S. FDA APPROVED A SUPPLEMENTAL NEW DRUG APPLICATION FOR TRINTELLIX (VORTIOXETINE)

* FOCUS AND CONNECT STUDIES SHOW TRINTELLIX HAS A POSITIVE EFFECT ON PROCESSING SPEED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below